However, the detrimental effects of anti-CD122 mAb cannot be attributed to NK cells in this study, as depletion of NK cells with anti-NK1.1 did not enlarge the brain infarct as had been observed in anti-CD122–treated stroke mice. This evidence concerns the gene IL2RB and brain infarction.